GNI Group (TSE:2160) Days Inventory : 147.22 (As of Dec. 2023)

View and export this data going back to 2007. Start your Free Trial

What is GNI Group Days Inventory?

Days Inventory is also known as Days Sales of Inventory (DSI). GNI Group's Average Total Inventories for the three months ended in Dec. 2023 was 円1,952 Mil. GNI Group's Cost of Goods Sold for the three months ended in Dec. 2023 was 円1,210 Mil. Hence, GNI Group's Days Inventory for the three months ended in Dec. 2023 was 147.22.

The historical rank and industry rank for GNI Group's Days Inventory or its related term are showing as below:

TSE:2160' s Days Inventory Range Over the Past 10 Years
Min: 183.34 Med: 266.52 Max: 419.19
Current: 183.34

During the past 13 years, GNI Group's highest Days Inventory was 419.19. The lowest was 183.34. And the median was 266.52.

TSE:2160's Days Inventory is ranked better than
51.85% of 650 companies
in the Biotechnology industry
Industry Median: 190.305 vs TSE:2160: 183.34

GNI Group's Days Inventory declined from Dec. 2022 (203.69) to Dec. 2023 (147.22).

Inventory Turnover measures how fast the company turns over its inventory within a year. GNI Group's Inventory Turnover for the three months ended in Dec. 2023 was 0.62.

Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue. GNI Group's Inventory-to-Revenue for the three months ended in Dec. 2023 was 0.36.

GNI Group Days Inventory Historical Data

The historical data trend for GNI Group's Days Inventory can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

GNI Group Days Inventory Chart

GNI Group Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Days Inventory

Get a 7-Day Free Trial

246.35

205.62

264.26

209.91

205.17

GNI Group Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Days Inventory	Get a 7-Day Free Trial															203.69	270.70	201.55	144.54	147.22

Competitive Comparison of GNI Group's Days Inventory

For the Biotechnology subindustry, GNI Group's Days Inventory, along with its competitors' market caps and Days Inventory data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

GNI Group's Days Inventory Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, GNI Group's Days Inventory distribution charts can be found below:

* The bar in red indicates where GNI Group's Days Inventory falls into.

GNI Group Days Inventory Calculation

Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

GNI Group's Days Inventory for the fiscal year that ended in Dec. 2023 is calculated as

	Days Inventory (A: Dec. 2023 )
=	Average Total Inventories					/	Cost of Goods Sold	*	Days in Period
=	( (Total Inventories (A: Dec. 2022 )	+	Total Inventories (A: Dec. 2023 ))	/	count )	/	Cost of Goods Sold (A: Dec. 2023 )	*	Days in Period
=	( (1693.412	+	2330.622)	/	2 )	/	3579.396	*	365
=	2012.017					/	3579.396	*	365
=	205.17

GNI Group's Days Inventory for the quarter that ended in Dec. 2023 is calculated as:

	Days Inventory (Q: Dec. 2023 )
=	Average Total Inventories					/	Cost of Goods Sold	*	Days in Period
=	( (Total Inventories (Q: Sep. 2023 )	+	Total Inventories (Q: Dec. 2023 ))	/	count )	/	Cost of Goods Sold (Q: Dec. 2023 )	*	Days in Period
=	( (1573.751	+	2330.622)	/	2 )	/	1209.976	*	365 / 4
=	1952.1865					/	1209.976	*	365 / 4
=	147.22

GNI Group (TSE:2160) Days Inventory Explanation

Days Inventory indicates the liquidity of the inventory. Generally, a lower Days Inventory is preferred as it indicates a shorter duration to clear off the inventory. An increase of the ratio may indicate the company's sales slowed. Similar ratios related to Days Inventory are:

1. Inventory Turnover measures how fast the company turns over its inventory within a year.

GNI Group's Inventory Turnover for the three months ended in Dec. 2023 is calculated as

Inventory Turnover	=	Cost of Goods Sold	/	Average Total Inventories
	=	1209.976	/	1952.1865
	=	0.62

2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.

GNI Group's Inventory to Revenue for the three months ended in Dec. 2023 is calculated as

Inventory-to-Revenue	=	Average Total Inventories	/	Revenue
	=	1952.1865	/	5462.676
	=	0.36

Be Aware

A lot of business are seasonable. It makes more sense to compare Days Inventory from the same period in the previous year instead of from the previous quarter.

GNI Group Days Inventory Related Terms

Thank you for viewing the detailed overview of GNI Group's Days Inventory provided by GuruFocus.com. Please click on the following links to see related term pages.

GNI Group (TSE:2160) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » GNI Group Ltd (TSE:2160) » Definitions » Days Inventory

Comparable Companies

Traded in Other Exchanges

3G6:Germany

Address

Shinjuku Park Tower, 3-7-1 Nishi-Shinjuku, Shinjuku-ku, Tokyo, JPN, 163-1030

Website

http://www.gnipharma.com

GNI Group Ltd is a clinical stage drug development company. It works on the treatment of diseases that are more common in Asia, especially Japan and China. It is engaged in the discovery, development, manufacture, and sale of drugs for the treatment of cancer and inflammatory diseases.

GNI Group (TSE:2160) Headlines

No Headlines